Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve 1. Un-audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Oxygenta Pharmaceutical has informed the BSE that its Board of Directors will meet on Thursday, 14th August 2025 at the registered office. The main agenda is to consider and approve the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26), along with the Limited Review Report by the auditors. Any other business with the Chair's permission may also be taken up. No financial numbers or outcomes are disclosed in this intimation — the actual results will be known after the meeting.
This is a routine regulatory filing ahead of the Q1 results announcement. Investors should watch for the actual results on or after 14th August 2025 for any meaningful impact on the stock; no immediate price action is expected from this notice alone.